Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Biotechnology  >  General Biotech

Amgen Inc. - SWOT Analysis - SWOT Analysis


Published Date: November 2008
Published By: Datamonitor
Page Count: 28
Order Code: R313-41677
 
DescriptionTable of ContentsSimilar
Products

Datamonitor's Amgen, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Amgen is a biotechnology company engaged in discovering, developing, manufacturing, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. The company primarily operates in the US. The company is headquartered in Thousand Oaks, California and employs about 17,500 people. The company recorded revenues of $14,771 million during the financial year (FY) ended December 2007, an increase of 3.5% over 2006. This increase in revenue was primarily driven by increase in sales of Enbrel and Neulasta. The operating profit of the company was $3,980 million during FY2007, an increase of 3.6% over 2006. The net profit was $3,166 million in FY2007, an increase of 7.3% over 2006.

Scope of the Report
  • Provides all the crucial company information required for business and competitor intelligence needs
  • Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
  • Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
  • Support sales activities by understanding your customers’ businesses better
  • Qualify prospective partners and suppliers
  • Keep fully up to date on your competitors’ business structure, strategy and prospects
  • Obtain the most up to date company information available

Similar Products
Pharmaceutical Manufacture and Sale
Published Dec 2008 by First Research, Inc.


Baxter International Inc.
Published Dec 2008 by SGA Lists


Albany Molecular Research, Inc.
Published Dec 2008 by SGA Lists


Amgen Inc.
Published Dec 2008 by SGA Lists


Affymetrix, Inc.
Published Dec 2008 by SGA Lists


PharmaNet Development Group, Inc.
Published Dec 2008 by SGA Lists


Novo Nordisk Incorporated
Published Dec 2008 by SGA Lists


Neurocrine Biosciences, Incorporated
Published Dec 2008 by SGA Lists


Millipore Corporation
Published Dec 2008 by SGA Lists


Parexel International Corporation
Published Dec 2008 by SGA Lists




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com